This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway
Biological Procedures Online Open Access 05 January 2024
-
The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Cell Death & Disease Open Access 11 November 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Debaugnies, M. et al. RHOJ controls EMT-associated resistance to chemotherapy. Nature 616, 168–175 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dart, A. EMT in chemoresistance. Nat Rev Cancer 23, 349 (2023). https://doi.org/10.1038/s41568-023-00581-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-023-00581-7
This article is cited by
-
MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway
Biological Procedures Online (2024)
-
Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma
Investigational New Drugs (2024)
-
The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Cell Death & Disease (2023)